BIB

ProShares Ultra Nasdaq Biotechnology

NASDAQ Biotechnology TR USD

NAV as of 29-Nov-2023

44.0320

4 Week: 41.74 - 48.20

52 Week: 40.35 - 62.61

Latest Closing Price

47.55

Premium / Discount

0.04

Expense Ratio

0.95%

Investment Objective

The investment seeks daily investment results that correspond to two times (2x) the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.

Main Fund Characteristics

Fund Manager:
ProShares
Asset Under Management:
82,999,313
Launch Date:
05/04/2010
Asset Class:
Miscellaneous
Replication Method:
Derivative Based
Number of Holdings:
263
Trading Currency:
USD
Style:
Mid Blend
Region/Sector/Strategy:
N.A / N.A / Equity
Exchange:
NASDAQ

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-17.591.98-8.88
1 Day-1.350.000.00
1 Week2.272.780.82
1 Month7.5510.040.75
3 Months-7.5116.99-0.44
6 Months-13.0120.69-0.63
1 Year-23.0832.27-0.72
2 Years-42.2265.79-0.64
3 Years-44.1278.56-0.56
5 Years-3.31112.40-0.03
10 Years-67.28188.11-0.36

Price History

-

Annual Performance Return

2013201420152016201720182019202020212022
Price (%) 160.138266.697613.7964-44.225140.7379-24.362445.504639.7412-5.9111-28.6357
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
21/12/202229/12/20220.0198
20/09/201027/09/20100.0439

Portfolio Data

Total Number of Holdings: 263

Number of Bond Holdings: 0

Number of Equity Holdings: 262

Total Market Value: 82,999,313

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Amgen Inc7.608820,45705,431,743

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant5.17
Large29.37
Medium22.31
Small12.63
Micro9.40

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

14.1840

Price/Book*

2.9061

Price/Sales*

3.8933

Price/Cash Flow*

12.2845

Dividend Yield*

1.0207

Growth Measures

Long-Term Earnings

5.8734

Historical Earnings

3.2155

Sales Growth

11.8316

Cash-Flow Growth

6.6256

Book-Value Growth

6.3221

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.

Contact us to Open an Account

Need Assistance? Share your Details and we’ll get back to you